A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A

The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular biology 1993-03, Vol.230 (1), p.206-226
Hauptverfasser: Kim, Kyung H., Willingmann, Peter, Gong, Zu Xun, Kremer, Marcia J., Chapman, Michael S., Minor, Iwona, Oliveira, Marcos A., Rossmann, Michael G., Andries, Koen, Diana, Guy D., Dutko, Frank J., McKinlay, Mark A., Pevear, Daniel C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 226
container_issue 1
container_start_page 206
container_title Journal of molecular biology
container_volume 230
creator Kim, Kyung H.
Willingmann, Peter
Gong, Zu Xun
Kremer, Marcia J.
Chapman, Michael S.
Minor, Iwona
Oliveira, Marcos A.
Rossmann, Michael G.
Andries, Koen
Diana, Guy D.
Dutko, Frank J.
McKinlay, Mark A.
Pevear, Daniel C.
description The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied by a cofactor or a drug. There are relatively small conformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drug in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14 and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes.
doi_str_mv 10.1006/jmbi.1993.1137
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75612330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002228368371137X</els_id><sourcerecordid>75612330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-fb07287cf63e39b88855b667c74d98aa0e6503bd257c61622c9c8958b574d3ad3</originalsourceid><addsrcrecordid>eNp1kEtLAzEURoMotT627oQsxN3UPJrHLGt9VCkoom5DJpNpU2eSmkwL_nuntnTn6l74zv24HAAuMBpghPjNoincAOc5HWBMxQHoYyTzTHIqD0EfIUIyIik_BicpLRBCjA5lD_QklVQI3AfPIzgOzVJHl4KHoYLt3MKRb10W586HtYu6hndxNYO3zpfOz-BrMF-2hc7DydsnHkLty79tdAaOKl0ne76bp-Dj4f59PMmmL49P49E0M5TLNqsKJIgUpuLU0ryQUjJWcC6MGJa51BpZzhAtSsKE4ZgTYnIjcyYL1gFUl_QUXG97lzF8r2xqVeOSsXWtvQ2rpATjmFCKOnCwBU0MKUVbqWV0jY4_CiO1kac28tRGntrI6w4ud82rorHlHt_Z6vKrXa6T0XUVtTcu7bEhpzljpMPkFrOdhbWzUSXjrDe2dNGaVpXB_ffBL91lh54</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75612330</pqid></control><display><type>article</type><title>A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kim, Kyung H. ; Willingmann, Peter ; Gong, Zu Xun ; Kremer, Marcia J. ; Chapman, Michael S. ; Minor, Iwona ; Oliveira, Marcos A. ; Rossmann, Michael G. ; Andries, Koen ; Diana, Guy D. ; Dutko, Frank J. ; McKinlay, Mark A. ; Pevear, Daniel C.</creator><creatorcontrib>Kim, Kyung H. ; Willingmann, Peter ; Gong, Zu Xun ; Kremer, Marcia J. ; Chapman, Michael S. ; Minor, Iwona ; Oliveira, Marcos A. ; Rossmann, Michael G. ; Andries, Koen ; Diana, Guy D. ; Dutko, Frank J. ; McKinlay, Mark A. ; Pevear, Daniel C.</creatorcontrib><description>The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied by a cofactor or a drug. There are relatively small conformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drug in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14 and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes.</description><identifier>ISSN: 0022-2836</identifier><identifier>EISSN: 1089-8638</identifier><identifier>DOI: 10.1006/jmbi.1993.1137</identifier><identifier>PMID: 8383771</identifier><identifier>CODEN: JMOBAK</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Amino Acid Sequence ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; antiviral ; Antiviral agents ; Antiviral Agents - chemistry ; Binding Sites ; Biological and medical sciences ; Capsid - ultrastructure ; Conserved Sequence ; Drug Design ; drugs ; HRV14 ; HRV1A ; Isoxazoles - chemistry ; Medical sciences ; Models, Molecular ; Molecular Sequence Data ; Pharmacology. Drug treatments ; Pyridazines - chemistry ; rhinovirus ; Rhinovirus - classification ; Rhinovirus - drug effects ; Rhinovirus - ultrastructure ; Sequence Alignment ; Serotyping ; Structure-Activity Relationship</subject><ispartof>Journal of molecular biology, 1993-03, Vol.230 (1), p.206-226</ispartof><rights>1993 Academic Press</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-fb07287cf63e39b88855b667c74d98aa0e6503bd257c61622c9c8958b574d3ad3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/jmbi.1993.1137$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4639552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8383771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Kyung H.</creatorcontrib><creatorcontrib>Willingmann, Peter</creatorcontrib><creatorcontrib>Gong, Zu Xun</creatorcontrib><creatorcontrib>Kremer, Marcia J.</creatorcontrib><creatorcontrib>Chapman, Michael S.</creatorcontrib><creatorcontrib>Minor, Iwona</creatorcontrib><creatorcontrib>Oliveira, Marcos A.</creatorcontrib><creatorcontrib>Rossmann, Michael G.</creatorcontrib><creatorcontrib>Andries, Koen</creatorcontrib><creatorcontrib>Diana, Guy D.</creatorcontrib><creatorcontrib>Dutko, Frank J.</creatorcontrib><creatorcontrib>McKinlay, Mark A.</creatorcontrib><creatorcontrib>Pevear, Daniel C.</creatorcontrib><title>A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A</title><title>Journal of molecular biology</title><addtitle>J Mol Biol</addtitle><description>The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied by a cofactor or a drug. There are relatively small conformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drug in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14 and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes.</description><subject>Amino Acid Sequence</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>antiviral</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemistry</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Capsid - ultrastructure</subject><subject>Conserved Sequence</subject><subject>Drug Design</subject><subject>drugs</subject><subject>HRV14</subject><subject>HRV1A</subject><subject>Isoxazoles - chemistry</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridazines - chemistry</subject><subject>rhinovirus</subject><subject>Rhinovirus - classification</subject><subject>Rhinovirus - drug effects</subject><subject>Rhinovirus - ultrastructure</subject><subject>Sequence Alignment</subject><subject>Serotyping</subject><subject>Structure-Activity Relationship</subject><issn>0022-2836</issn><issn>1089-8638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLAzEURoMotT627oQsxN3UPJrHLGt9VCkoom5DJpNpU2eSmkwL_nuntnTn6l74zv24HAAuMBpghPjNoincAOc5HWBMxQHoYyTzTHIqD0EfIUIyIik_BicpLRBCjA5lD_QklVQI3AfPIzgOzVJHl4KHoYLt3MKRb10W586HtYu6hndxNYO3zpfOz-BrMF-2hc7DydsnHkLty79tdAaOKl0ne76bp-Dj4f59PMmmL49P49E0M5TLNqsKJIgUpuLU0ryQUjJWcC6MGJa51BpZzhAtSsKE4ZgTYnIjcyYL1gFUl_QUXG97lzF8r2xqVeOSsXWtvQ2rpATjmFCKOnCwBU0MKUVbqWV0jY4_CiO1kac28tRGntrI6w4ud82rorHlHt_Z6vKrXa6T0XUVtTcu7bEhpzljpMPkFrOdhbWzUSXjrDe2dNGaVpXB_ffBL91lh54</recordid><startdate>19930305</startdate><enddate>19930305</enddate><creator>Kim, Kyung H.</creator><creator>Willingmann, Peter</creator><creator>Gong, Zu Xun</creator><creator>Kremer, Marcia J.</creator><creator>Chapman, Michael S.</creator><creator>Minor, Iwona</creator><creator>Oliveira, Marcos A.</creator><creator>Rossmann, Michael G.</creator><creator>Andries, Koen</creator><creator>Diana, Guy D.</creator><creator>Dutko, Frank J.</creator><creator>McKinlay, Mark A.</creator><creator>Pevear, Daniel C.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930305</creationdate><title>A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A</title><author>Kim, Kyung H. ; Willingmann, Peter ; Gong, Zu Xun ; Kremer, Marcia J. ; Chapman, Michael S. ; Minor, Iwona ; Oliveira, Marcos A. ; Rossmann, Michael G. ; Andries, Koen ; Diana, Guy D. ; Dutko, Frank J. ; McKinlay, Mark A. ; Pevear, Daniel C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-fb07287cf63e39b88855b667c74d98aa0e6503bd257c61622c9c8958b574d3ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Amino Acid Sequence</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>antiviral</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemistry</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Capsid - ultrastructure</topic><topic>Conserved Sequence</topic><topic>Drug Design</topic><topic>drugs</topic><topic>HRV14</topic><topic>HRV1A</topic><topic>Isoxazoles - chemistry</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridazines - chemistry</topic><topic>rhinovirus</topic><topic>Rhinovirus - classification</topic><topic>Rhinovirus - drug effects</topic><topic>Rhinovirus - ultrastructure</topic><topic>Sequence Alignment</topic><topic>Serotyping</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Kyung H.</creatorcontrib><creatorcontrib>Willingmann, Peter</creatorcontrib><creatorcontrib>Gong, Zu Xun</creatorcontrib><creatorcontrib>Kremer, Marcia J.</creatorcontrib><creatorcontrib>Chapman, Michael S.</creatorcontrib><creatorcontrib>Minor, Iwona</creatorcontrib><creatorcontrib>Oliveira, Marcos A.</creatorcontrib><creatorcontrib>Rossmann, Michael G.</creatorcontrib><creatorcontrib>Andries, Koen</creatorcontrib><creatorcontrib>Diana, Guy D.</creatorcontrib><creatorcontrib>Dutko, Frank J.</creatorcontrib><creatorcontrib>McKinlay, Mark A.</creatorcontrib><creatorcontrib>Pevear, Daniel C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Kyung H.</au><au>Willingmann, Peter</au><au>Gong, Zu Xun</au><au>Kremer, Marcia J.</au><au>Chapman, Michael S.</au><au>Minor, Iwona</au><au>Oliveira, Marcos A.</au><au>Rossmann, Michael G.</au><au>Andries, Koen</au><au>Diana, Guy D.</au><au>Dutko, Frank J.</au><au>McKinlay, Mark A.</au><au>Pevear, Daniel C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A</atitle><jtitle>Journal of molecular biology</jtitle><addtitle>J Mol Biol</addtitle><date>1993-03-05</date><risdate>1993</risdate><volume>230</volume><issue>1</issue><spage>206</spage><epage>226</epage><pages>206-226</pages><issn>0022-2836</issn><eissn>1089-8638</eissn><coden>JMOBAK</coden><abstract>The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied by a cofactor or a drug. There are relatively small conformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drug in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14 and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>8383771</pmid><doi>10.1006/jmbi.1993.1137</doi><tpages>21</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2836
ispartof Journal of molecular biology, 1993-03, Vol.230 (1), p.206-226
issn 0022-2836
1089-8638
language eng
recordid cdi_proquest_miscellaneous_75612330
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Amino Acid Sequence
Antibiotics. Antiinfectious agents. Antiparasitic agents
antiviral
Antiviral agents
Antiviral Agents - chemistry
Binding Sites
Biological and medical sciences
Capsid - ultrastructure
Conserved Sequence
Drug Design
drugs
HRV14
HRV1A
Isoxazoles - chemistry
Medical sciences
Models, Molecular
Molecular Sequence Data
Pharmacology. Drug treatments
Pyridazines - chemistry
rhinovirus
Rhinovirus - classification
Rhinovirus - drug effects
Rhinovirus - ultrastructure
Sequence Alignment
Serotyping
Structure-Activity Relationship
title A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T20%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparison%20of%20the%20Anti-rhinoviral%20Drug%20Binding%20Pocket%20in%20HRV14%20and%20HRV1A&rft.jtitle=Journal%20of%20molecular%20biology&rft.au=Kim,%20Kyung%20H.&rft.date=1993-03-05&rft.volume=230&rft.issue=1&rft.spage=206&rft.epage=226&rft.pages=206-226&rft.issn=0022-2836&rft.eissn=1089-8638&rft.coden=JMOBAK&rft_id=info:doi/10.1006/jmbi.1993.1137&rft_dat=%3Cproquest_cross%3E75612330%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75612330&rft_id=info:pmid/8383771&rft_els_id=S002228368371137X&rfr_iscdi=true